High-Risk Medication

ECHO® Series

Partner Impact

Wake Up Wednesday: High-Risk Medication ECHO® Series

Nursing home teams, prescribers, pharmacists, admission and discharge planners, and many others across the care continuum share a common goal to improve patient outcomes. In 2023, Telligen hosted a series to address unsafe medication practices and medication errors which are a leading cause of injury and avoidable harm in health care systems. During this series, experts shared key information focusing on improving care coordination practices that support high-risk medication management, resident safety and quality of care.

Outcome Goals Set

    • Decrease opioid adverse drug events (ADEs) including deaths for high-risk patients in nursing homes
    • Decrease ADEs in nursing homes (high-risk meds – opioids, anticoagulants, diabetics)
    • Decrease preventable emergency department visits for LTC residents
    • Decrease 30-day unplanned rehospitalizations for LTC residents
    • Decrease prescribing of high-risk meds including antipsychotics
    • Improve long-stay antipsychotics quality measure rating
    • 75% of Telligen communities (36) have one or more provider from each attend at least one session
    • Improvement indicated in the pre- to post-polling questions at each session

Outcome Goals Set

    • Decrease opioid adverse drug events (ADEs) including deaths for high-risk patients in nursing homes
    • Decrease ADEs in nursing homes (high-risk meds – opioids, anticoagulants, diabetics)
    • Decrease preventable emergency department visits for LTC residents
    • Decrease 30-day unplanned rehospitalizations for LTC residents
    • Decrease prescribing of high-risk meds including antipsychotics
    • Improve long-stay antipsychotics quality measure rating
    • 75% of Telligen communities (36) have one or more provider from each attend at least one session
    • Improvement indicated in the pre- to post-polling questions at each session

Telligen’s Impact & Participant Feedback

Nursing homes that attended at least one live session showed a relative improvement in high-risk medication (opioid, anticoagulants, antidiabetics) ADE encounters as well as prescribing antipsychotic medications over nursing homes that never registered.

Series Results

Upon a 30-day follow up, respondents attested:

  • 50% identified changes needed in practice

  • 33% increased participation in shared decision making within the team and the care continuum

  • 33% shared information with others to improve processes and resident outcomes

 

“Thank you, this is a great format for learning!  Short and to the point with application in the case study.  Really well done!”

“This was fabulous. Thank you very much. We need to improve dramatically in this area.”

“Thank you. I used the series handouts to in-service my staff.”

“Great presentation! Love that this is a series of 30-minute conversations!!”

Registration and Participation Outcomes

402 Total Registrants

    • 348 unique registrations from the Telligen QI Connect™ four-state region
    • 54 unique registrations outside the Telligen QI Connect™ four-state region
    • 187 unique participants attended at least one session

97% of Telligen QI Connect™ communities attended at least one session!

As of April 2024:

    • 307 resource downloads
    • 699 page views
    • 286 engaged website sessions

Who We Help

nursing homes

clinicians

hospitals

community partners

patients & families